AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non-ST-Segment Elevation Acute Coronary Syndrome.

Pedro E P Carvalho¹, Will Belzer¹, Daniel L Pollmann², Hans C Helseth³, Jay H Traverse⁴, Robert Herman⁵, Deniz Mutlu¹, Anil Poulose⁴, Michael Mooney⁴, M Nicholas Burke⁴, Konstantinos Voudris⁴, Mario Goessl⁴, Ivan Chavez⁴, Yale L Wang⁴, Dimitrios Strepkos¹, Michaella Alexandrou¹, Ellen Cravero⁶, Bavana V Rangan¹, Allan S Jaffe⁷, Emmanouil S Brilakis⁸, Scott W Sharkey¹, Yader Sandoval⁹

¹Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

²Department of Internal Medicine, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

³Emergency Department, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

⁴Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

⁵Cardiovascular Center Aalst, AZORG, Aalst, Belgium; Powerful Medical, Bratislava, Slovakia.

⁶Biostatistic Unit, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

⁷Department of Cardiovascular Medicine and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.

⁸Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

⁹Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Electronic address: yadersandoval@gmail.com.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) improves detection of occlusive myocardial infarction (OMI) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) compared with standard of care (SOC) remains uncertain. OBJECTIVES: The objective of the study was to evaluate an AI-ECG model for detecting OMI among patients with suspected high-risk NSTE-ACS…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.